Outcomes of adult heroin users v. abstinent users four years after presenting for heroin detoxification treatment by Khan, Zureida et al.
82    SAJP  -  August 2014  Vol. 20  No. 3 
ARTICLE
Outcomes of adult heroin users v. abstinent users four years 
after presenting for heroin detoxification treatment 
Z Khan,1 MB ChB, FCPsych, MMed (Psych); K J Cloete,1 PhD; J Harvey,2 PhD; L Weich,1 MB ChB, MRCPsych, FCPsych
1 Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, Cape Town, South Africa
2 Centre for Statistical Consultation, Stellenbosch University, Cape Town, South Africa
Corresponding author: L Weich (lizew@sun.ac.za)
Background. There are no studies in South Africa (SA) on the outcomes following detoxification and psychosocial rehabilitation of heroin-
dependent patients.
Objective. To compare the demographic, clinical, forensic and treatment data of active heroin users v. users who were abstinent at the time 
of interview 4 years after attending the Opioid Detoxification Unit at Stikland Hospital in the Western Cape Province, SA. 
Method. Participants included patients above the age of 16 years who had been admitted to the Opioid Detoxification Unit at Stikland 
Hospital for heroin detoxification between July 2006 and June 2007. Participants were individually interviewed (either in person or tele-
phonically) using a structured self-report questionnaire to collect demographic, clinical, forensic and treatment data 4 years following 
heroin detoxification treatment at this unit. 
Results. Of the participants, 60% were abstinent and a large portion (34%) attributed this to social support. Furthermore, there was a 
significant (p=0.04) difference in the longest period of abstinence between the past user group and active users, with more participants in 
the past user group being abstinent for 18 months or longer (n=24, 57%) than in the active users group (n=8, 29%). Active users (n=18, 64%) 
had significantly (p=0.03) more legal problems than abstinent users (n=14, 33%). Most participants (n=38, 54%) relapsed within 3 months 
after index detoxification and rehabilitation. 
Conclusion. Active users had more legal problems than abstinent users, with social support structures playing a pivotal role in abstinence. 
Future research should assess the impact of interventions such as post-discharge social support programmes on criminality and heroin use 
in those that relapse following treatment.
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Heroin is the fourth most frequently abused substance 
in patients presenting for substance abuse treatment 
in South Africa (SA), with a recorded prevalence 
of 7.9%. [1] In the Western Cape Province, heroin is 
the main illicit opioid abused, with a trend towards 
increased use. Statistics from the SA Community Epidemiology 
Network on Drug Use project showed a 15% increase in patients 
presenting for heroin treatment in the Western Cape between 1996 
and 2012.[2] 
Opioid use disorders are medically treated by placing patients either 
on a maintenance substitution opioid to reduce harm and illicit opioid 
use, or by detoxifying patients and implementing relapse prevention 
strategies. Opioid substitution treatment has the best outcomes and is 
therefore the treatment of choice in most countries.[3] In SA, however, 
opioid use disorder is mainly treated by medical detoxification 
followed by psychosocial rehabilitation to prevent relapse. 
The Opioid Detoxification Unit at Stikland Hospital in Cape Town, 
Western Cape, is currently the only state-run, purpose-built facility 
in SA that the authors are aware of, where opioid-dependent patients 
are assessed, detoxified and treated for medical comorbidity. The 
unit has ten beds and is funded by the Western Cape Provincial 
Department of Health. Patients are referred from a rehabilitation 
agency and admitted for an average period of 1 week. They are 
medicated with an individualised dose of either buprenorphine/
naloxone or methadone, which is calculated and titrated against 
objectively rated withdrawal symptoms and gradually tapered off. 
Besides detoxification treatment at the unit, patients are also offered 
privately funded substitution treatment if they are suitable candidates, 
willing and able to cover treatment costs. Detoxification is followed 
by either an in- or outpatient psychosocial rehabilitation programme 
provided by one of the social welfare-funded rehabilitation centres. 
In developed countries, many large prospective cohort studies 
have reported on outcomes following opioid dependence treatment. 
These include the Drug Abuse Reporting Programme (DARP), 
Treatment Outcomes Prospective Study (TOPS), and Drug Abuse 
Treatment Outcomes Studies (DATOS) in the United States,[4] the 
National Treatment Outcomes Research Study (NTORS) in the United 
Kingdom,[5] the Australian Treatment Outcome Study in Australia,[6] 
and the Amsterdam Cohort in the Netherlands.[7] These studies showed 
that length of treatment predicts outcome, with treatment periods of 
>3 months showing higher rates and longer periods of abstinence. 
Furthermore, opioid substitution and community-based treatment 
were found to be effective in reducing drug use and criminal behav-
iour. As oral opioid substitution rather than opioid detoxification 
therapy is becoming the standard treatment of choice in most countries, 
most of the recent international studies include outcomes following 
opioid substitution therapy.[4-6] However, a study by Gandhi et al.[8] on 
the short-term outcomes of a 3-day ambulatory opioid detoxification 
programme reported a reduction in the severity of dependence for 
some younger heroin users who may not yet be ready to engage in 
long-term abstinence-oriented or opioid substitution treatments.
There are no studies on the clinical, social or forensic outcomes 
following detoxification and psychosocial rehabilitation of heroin-
dependent patients treated at the Opioid Detoxification Unit, nor 
are there studies comparing long-term clinical, social and forensic 
outcomes for active heroin users v. users who managed to become 
abstinent following treatment. Additionally, as a developing country, 
SA is faced with numerous challenges such as high unemployment 
rates and very limited social welfare grants, and outcomes in this 
setting may therefore not reflect findings from international reports. 
Furthermore, there are no state-funded methadone or buprenorphine 
substitution programmes in SA where a strong emphasis is placed on 
total abstinence as the only successful treatment option for patients 
with heroin use disorders.
Objective
The objective was to assess the outcomes of heroin- depend ent 
patients 4 years after detoxification at the Opioid Detoxification Unit, 
by comparing the demographic, forensic, clinical and treatment data 
between patients with heroin use disorders who were actively using at 
the time of investigation and those who had been abstinent for at least 
the previous 4 weeks at the time of investigation.
Method
Study design and setting
This was a retrospective cohort study conducted at the Opioid 
Detoxification Unit from October 2010 to July 2011.
Definitions
Legal problems included self-reported arrests without charges, 
pending criminal charges, convictions and criminal activities that 
were not reported to the police or correctional services. The index 
episode was defined as the first admission for heroin detoxification 
at the Opioid Detoxification Unit. A readmission was defined 
as a readmission after the index episode to either the Opioid 
Detoxification Unit or any other substance treatment programme 
for heroin use disorder. Users who were considered abstinent at the 
time of interview were defined as not having used heroin for at least 
the previous 4 weeks. Support structures included family, friends and 
various organisations such as day-patient programmes and aftercare 
support groups run by substance treatment programmes, self-help 
support groups such as Narcotics Anonymous, and support from and 
involvement with religious institutions.
Study population
The study population included all patients aged 16 years or older 
admitted to the Opioid Detoxification Unit specifically for heroin 
detoxification during the period June 2006 to July 2007. Patients were 
included regardless of whether they completed or terminated the 
programme. The unit does not admit patients younger than 16 years 
old, and patients admitted for detoxification from opioids other than 
heroin were excluded from the study. 
Data collection
Participants were interviewed 4 years after attending the Opioid 
Detoxification Unit either: (i) telephonically; (ii) in person at their local 
community health centre; or (iii) in person at the Opioid Detoxification 
Unit if readmitted during the study period. Participants were interviewed 
using a structured, interviewer-administered questionnaire to collect 
demographic, forensic, clinical and treatment data.
Demographic data included age, gender, education, employment, 
length of employment and marital status after treatment. Forensic 
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data included variables as defined under 
legal problems above. Clinical data included 
frequency of heroin use per day, mode 
of administration, all health problems, 
psychiatric problems and type of psychiatric 
disorders during the 4 years after treatment. 
Treatment data included admission details, 
details of treatment during admission, 
abstinence after treatment, rehabilitation 
details and details pertaining to social 
support structures.
Data analyses
The data were captured using Windows Excel 
software (Microsoft, USA) and analysed using 
Statistica version 10 (StatSoft Inc., USA). 
Continuous variables such as age were 
summarised using means and standard 
deviations (SDs). Absolute and relative 
frequencies were calculated for all 
categorical variables. Pearson’s χ2 or the 
t-test for independent samples was used to 
compare categorical variables for active v. 
abstinent users. In cases where low expected 
frequencies were observed, the Fisher’s 
exact test was used to confirm findings. 
Contingency tables were used to show 
differences in frequencies for categorical 
variables between active and abstinent users. 
Significance was set at p<0.05, while 
95% confidence intervals (CIs) were used 
to describe the estimation of unknown 
parameters.
Ethical considerations
Ethical approval was obtained from the 
Health Research Ethics Committee at 
Stellenbosch University. Prior to telephonic 
interview, informed consent was obtained 
from each participant after telephonically 
explaining the consent form to them in their 
preferred language. In the case of face-to-
face interviews, participants provided written 
informed consent using the aforementioned 
form. Each participant was assigned a 
study number to ensure anonymity and 
preserve confidentiality. The data were kept 
confidential in a password-protected file on a 
computer used only by the investigator.
Results 
Participants
The study population included 189 
participants and complete data were collected 
for 70 (37%) respondents. The following 
patients were not included in the final sample: 
4 who died in the last 4 years, 23 who refused 
to participate, 23 who were untraceable 
due to irregular contact with their families, 
and 69 who were not contactable on their 
recorded telephone numbers. 
Most participants (n=42, 60%) reported 
being abstinent from heroin at the time of 
investigation, while 26 (37%) reported being 
completely abstinent since index admission.
Over one-third of participants (n=24, 34%) 
attri buted abstinence to social support struc-
tures, while 15 (21%) attributed absti nence to 
self- funded oral substitution pharmaco therapy. 
The number of treatment episodes was not 
significantly associated with better outcomes 
(p=0.55).
Demographic data 
There was no significant difference in age, 
gender, education, employment status, length 
of employment or marital status between active 
users and users who were abstinent at the time 
of interview (Table 1). The mean (SD) age of 
the entire group was 29.1 (5.8) years (95% CI 
27.74 - 30.49) years. Most participants in both 
groups were single and male. The users who 
were not actively using at the time of interview 
were more likely to have a Grade 12 level of 
education, while active users were more likely 
to have a Grade 10 level of education, but this 
finding was not statistically significant (p=0.12). 
Although there was a greater percentage of 
abstinent users who had been employed for 
3 - 5 months (n=12, 52%) compared with 
active users (n=4, 40%), this finding was not 
statistically significant (p=0.89). 
Forensic data
There was a significant (p=0.03) difference 
in the number of legal problems since index 
admission between the groups, with more 
participants in the active users group (n=18, 
Table 1. Demographic data of active heroin users v. abstinent users 4 years after admis-
sion for heroin detoxification at the Opiod Detoxification Unit at Stikland Hospital
 Active users Abstinent users  p-value
Age, years (mean (SD), 95% CI) 28 (5.8, 26.72 - 29.42) 30 (3.5, 27.69 - 91.33) 0.22
n % n %
Gender 0.81
Male 22 79 32 76
Female 6 21 10 24
Education 0.12
Grade 9 2 7 3 7
Grade 10 12 43 8 19
Grade 11 8 29 10 24
Grade 12 4 14 13 31
 Tertiary level (university or 
college) 2 7 8 19
Employment 0.14
Yes 10 36 23 55
No 18 64 19 45
Length of employment, months 0.89
<3 2 20 4 17
3 - 5 4 40 12 52
6 - 12 3 30 6 27
>12 1 10 1 4
Marital status 0.36
Single 17 61 25 60
Married 7 25 14 33
Divorced 4 14 2 5
Widowed 0 0 1 2
SD = standard deviation; CI = confidence interval.
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64%) than in the abstinent users group (n=14, 33%) having legal 
problems (Table 2). Although non-significant (p=0.55), there were 
also more active users (n=17, 94%) than past users (n=11, 85%) with 
heroin-related legal problems. However, most participants in both 
groups did not report pending criminal charges and convictions.
Clinical data 
There was no significant difference between abstinent and active 
users for frequency of use, mode of administration, health and 
self-reported psychiatric problems or type of psychiatric disorders 
over the past 4 years (Table 3). Most active users (n=15, 54%) used 
heroin five times per day, with inhalation the most prevalent mode of 
administration in both active and abstinent users. Active users (n=2, 
67%) also had a higher rate of mood disorders than abstinent users 
(n=2, 40%); however, most participants in both groups did not report 
health or psychiatric problems over the past 4 years. 
Treatment data 
The largest proportion (n=25) of participants in both groups 
had been admitted and completed detoxification twice (Table 4). 
There was a significant (p=0.04) difference in the longest period 
of abstinence between active and abstinent users, with more 
participants in the currently abstinent group (n=24, 62%) being 
abstinent for ≥18 months than in active users (n=8, 31%). 
Although non-significant, there were more abstinent (n=25, 
59%) than active users (n=13, 46%) with an abstinence period 
of <3 months. Furthermore, there was a significant (p=0.02) 
difference in social support structures between active and 
abstinent users, with more participants in the currently abstinent 
group (n=42, 100%) having social support structures than active 
users (n=24, 86%). The majority of patients (n=38, 54%) relapsed 
within 3 months after index detoxification and rehabilitation. 
There was no significant difference between the groups for 
number of admissions, period of abstinence, readmission, private 
detoxification, rehabilitation after initial admission, type of 
rehabilitation, length of rehabilitation and for whether or not 
detoxification was completed.
Discussion
The objective of the study was to assess the outcome in heroin 
users 4 years after detoxification at the Opioid Detoxification Unit 
by specifically comparing the demo graphic, forensic, clinical and 
treatment data of active heroin users v. abstinent users. 
Interestingly, the results showed that 55% of the interviewed 
sample was abstinent 4 years after the index admission to the 
Opioid Detoxification Unit. This finding reflects abstinence rates 
reported by other studies. The NTORS reported a 49% abstinence 
rate after 4 - 5 years of residential treatment and a 57% abstinence 
rate with maintenance programmes.[9] The DATOS reported a 
reduction from 89% to 28% in weekly or more frequent heroin 
use 5 years after treatment.[5] It should, however, be noted that 
the NTORS and DATOS studies included four different types of 
treatment modalities as opposed to only detoxification and relapse 
prevention via rehabilitation. Furthermore, these studies included 
larger prospective cohorts with moderate attrition rates (DATOS 
20%, NTORS 24%), compared with the large number of untraceable 
participants lost to follow-up in the current retrospective report 
(49%). The high number of currently abstinent users should 
therefore be interpreted with caution, as these individuals are often 
more likely to be contactable in contrast to active users for various 
social reasons. Alternatively, the high number of abstinent users 
could be related to difficulties in maintaining addiction as SA 
substance users do not qualify for state grants. Furthermore, one-
Table 3. Clinical data of active heroin users v. abstinent users 
during the 4 years after admission for heroin detoxification at 
the Opioid Detoxification Unit at Stikland Hospital
Active users Abstinent users
p-valuen % n %
Frequency of use per day 0.74
1 3 11 - -
4 3 11 - -
5 15 53 - -
10 7 25 - -
Mode of administration 0.26
Inhalation 28 100 39 93
Injection 0 0 3 7
Health problems 0.67
Yes 3 11 3 7
No 25 89 39 93
Psychiatric problems 1.00
Yes 3 11 5 12
No 25 89 37 88
Type of psychiatric disorder 0.64
Mood 2 67 2 40
Psychosis 0 0 1 20
Other 1 33 2 40
Table 2. Forensic data of active heroin users v. abstinent users 
during the four years after admission for heroin detoxification at 
the Opioid Doxification Unit at Stikland Hospital
Active users Abstinent users
 p-valuen % n %
Legal problems 0.03*
Yes 18 64 14 33
No 10 36 28 67
Charges pending 0.23
Yes 3 17 0 0
No 15 83 14 100
Convictions 0.38
Yes 7 39 5 36
No 11 61 9 64
Heroin related 0.55
Yes 17 94 11 85
No 1 6 2 15
 *p<0.05, Fisher’s exact two-tailed test.
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fifth of our abstinent group attributed abstinence to self-funded oral 
substitution pharmacotherapy.
For most participants, social support structures were reported 
to play the most important role in abstinence. There was also a 
significant difference between the groups for longest period of 
abstinence, with more participants in the past user group with a 
period of abstinence >18 months, compared with active users. We are 
not aware of previous studies addressing duration of abstinence and 
its associated factors following detoxification and rehabilitation; this 
suggests the need for further research in this area. Nevertheless, the 
significant effect of social support structures on abstinence is similarly 
reflected in other reports. For example, Flynn et al.[10] reported that 
28% of NTORS patients in recovery 5 years following outpatient 
methadone maintenance programmes relied primarily upon personal 
motivation, treatment experiences, religion/spirituality, family and 
their job/career. Patients in this study placed particular value on social 
support from family and close friends. A study conducted by Ellis et 
al.[11] also concluded that positive family activities during the post-
discharge period significantly decreased the likelihood of relapse, 
while negative family activities such as fights and drug use or criminal 
activity by friends increased the likelihood of relapse. A study 
conducted by Best et al.[12] confirmed that while achieving abstinence 
is possible for chronic opiate users, the path to sustained abstinence is 
complex and often reliant upon external social support systems. 
There was no association between current abstinence (as defined 
above) and length of stay in rehabilitation. International large cohort 
studies such as DARP, TOPS, DATOS and NTORS all indicate 
better outcomes associated with a ≥3-month duration of treat-
ment. [4,9] It should, however, be noted that the duration of treatment 
for in- or outpatients did not exceed 12 weeks as government-
funded treatment programmes are usually 6 - 8 weeks in duration in 
our current setting. Only one of the 70 respondents had a treatment 
programme of 14 weeks’ duration, making it difficult to comment 
on this finding.
A total of 54% (n=38) of participants relapsed within the first 3 
months after index detoxi fication and rehabilitation. Similarly, studies 
such as NTORS re ported that 60% of patients relapsed within 90 days 
Table 4. Treatment data of active heroin users v. abstinent users 
during the 4 years after admission for heroin detoxification at 
the Opioid Detoxification Unit at Stikland Hospital
Active users  Abstinent users
p-valuen % n %
Total admissions 0.55
1 3 10 10 25
2 13 43 12 30
3 3 10 3 7.5
4 3 10 3 7.5
5 2 7 3 7.5
6 4 14 7 17.5
7 1 3 2 5
10 1 3 0 0
Detox completed 0.73
Yes 25 89 36 86
No 3 11 6 14
Period of abstinence 
after detox, months 0.35
<3 13 46 25 59
3 - 5 5 19 7 17
6 - 11 2 7 3 7
12 - 17 2 7 0 0
>18 6 21 7 17
Longest abstinence, 
months 0.04*
3 - 5 7 27 3 7
6 - 11 6 23 10 26
12 - 17 5 19 2 5
>18 8 31 24 62
Readmission 0.07
Yes 16 57 15 36
No 12 43 27 64
Private detoxification 0.45
Yes 16 57 28 67
No 12 43 14 33
Rehab after first  
admission 0.54
Yes 24 86 33 79
No 4 14 9 21
Type of rehabilitation 0.40
Inpatient 7 29 14 44
Outpatient 17 71 18 56
Continued ...
Table 4. Treatment data of active heroin users v. abstinent users 
during the 4 years after admission for heroin detoxification at the 
Opioid Detoxification Unit at Stikland Hospital  (Continued ...) 
Active users  Abstinent users
p-valuen % n %
Length of time in rehabilitation programmes (weeks) 0.71
1 1 4 1 3
2 2 8 2 7
3 1 4 3 10
4 0 0 1 3
5 1 4 0 0
7 6 23 10 33
8 12 45 7 24
10 2 8 3 10
12 1 4 2 7
14 0 0 1 3
Support structures 0.02*
Yes 24 86 42 100
No 4 14 0 0
*p<0.05, Pearson’s χ2 test, Fisher’s exact two-tailed test
ARTICLE
August 2014  Vol. 20  No. 3    -  SAJP    87
after treatment. [9] This is worrying, as legal problems were significantly 
more frequent in active users than abstinent users. Legal problems 
were based on self-reports and included not only pending charges and 
convictions, but also criminal activities not reported to the police or 
correctional services and arrest for acquisition crimes without charges 
or convictions. 
Nevertheless, the higher incidence of overall legal problems in 
active users is worrying, as criminal activity among active users 
may be further compounded by the high rates of heroin use and 
unemployment in SA.[13] Likewise, more active users (64%) tended 
to be unemployed than abstinent users. Unemployment is a possible 
confounding factor for increased criminal activity in active users who 
were possibly involved in criminal activity other than acquisition 
crimes to provide for other needs. Other possible confounders include 
criminal activity related to the use of other substances unrelated to 
heroin. The details pertaining to the use of substances other than 
heroin were not explored in this study and need to be further explored. 
Many international studies confirm that drug use increases the 
incidence of criminal activity.[4,14] Findings from a recent study 
by Sokya et al.[15] show a significant rate of criminal activity and 
convictions in patients entering opioid-substitution treatment and a 
decrease in criminal activities over time. Gossop et al.[5] also showed 
that longer periods of stay in methadone treatment were linked to 
greater reductions in both heroin use and criminal activity. 
The biggest limitation of this study was the large number of 
untraceable cases that may have biased the results. A further 
limitation was the relatively small sample size and the use of self-
report questionnaires. Under self-reporting conditions, there is 
potential response distortion not only of each measure, but also 
of correlations between measures. Self-reported answers may be 
exaggerated, respondents may be too embarrassed to reveal private 
details or forget pertinent details, while various other biases may 
also affect the results, such as the respondent’s feelings at the time of 
completion. Furthermore, and as with all studies relying on voluntary 
participation, results may be biased by a lack of respondents and if 
there are systematic differences between those who respond and those 
who do not respond. Nevertheless, this is the first descriptive study 
in SA comparing outcome data between active and abstinent users 
4 years following detoxification for heroin dependence.
Conclusion
The findings of this study are consistent with other outcome studies 
showing a reduction in legal problems following treatment and the 
pivotal role of social support structures in abstinence. Future research 
should assess the impact of interventions such as post-discharge social 
support programmes on criminality and heroin use in those who 
relapse following treatment.
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